BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25040471)

  • 1. Ataxia telangiectasia: more variation at clinical and cellular levels.
    Taylor AM; Lam Z; Last JI; Byrd PJ
    Clin Genet; 2015 Mar; 87(3):199-208. PubMed ID: 25040471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis.
    Taylor AM; Groom A; Byrd PJ
    DNA Repair (Amst); 2004; 3(8-9):1219-25. PubMed ID: 15279810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three new cases of ataxia-telangiectasia-like disorder: No impairment of the ATM pathway, but S-phase checkpoint defect.
    Fiévet A; Bellanger D; Valence S; Mobuchon L; Afenjar A; Giuliano F; Dubois d'Enghien C; Parfait B; Pedespan JM; Auger N; Rieunier G; Collet A; Burglen L; Stoppa-Lyonnet D; Stern MH
    Hum Mutat; 2019 Oct; 40(10):1690-1699. PubMed ID: 31033087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ataxia-telangiectasia: A review of clinical features and molecular pathology.
    Amirifar P; Ranjouri MR; Yazdani R; Abolhassani H; Aghamohammadi A
    Pediatr Allergy Immunol; 2019 May; 30(3):277-288. PubMed ID: 30685876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRE11 mutations and impaired ATM-dependent responses in an Italian family with ataxia-telangiectasia-like disorder.
    Delia D; Piane M; Buscemi G; Savio C; Palmeri S; Lulli P; Carlessi L; Fontanella E; Chessa L
    Hum Mol Genet; 2004 Sep; 13(18):2155-63. PubMed ID: 15269180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T-->G mutations, showing a less severe phenotype.
    Stewart GS; Last JI; Stankovic T; Haites N; Kidd AM; Byrd PJ; Taylor AM
    J Biol Chem; 2001 Aug; 276(32):30133-41. PubMed ID: 11382771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia.
    Lavin MF; Khanna KK
    Int J Radiat Biol; 1999 Oct; 75(10):1201-14. PubMed ID: 10549596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of ataxia telangiectasia and related diseases.
    Ball LG; Xiao W
    Acta Pharmacol Sin; 2005 Aug; 26(8):897-907. PubMed ID: 16038621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-associated MRE11 mutants impact ATM/ATR DNA damage signaling by distinct mechanisms.
    Regal JA; Festerling TA; Buis JM; Ferguson DO
    Hum Mol Genet; 2013 Dec; 22(25):5146-59. PubMed ID: 23912341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ataxia-telangiectasia: mild neurological presentation despite null ATM mutation and severe cellular phenotype.
    Alterman N; Fattal-Valevski A; Moyal L; Crawford TO; Lederman HM; Ziv Y; Shiloh Y
    Am J Med Genet A; 2007 Aug; 143A(16):1827-34. PubMed ID: 17632790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress in ataxia telangiectasia.
    Watters DJ
    Redox Rep; 2003; 8(1):23-9. PubMed ID: 12631440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two novel variants in the ATM gene causing ataxia-telangiectasia, including a duplication of 90 kb: Utility of targeted next-generation sequencing in detection of copy number variation.
    Martin-Rodriguez S; Calvo-Ferrer A; Ortega-Unanue N; Samaniego-Jimenez L; Sanz-Izquierdo MP; Bernardo-Gonzalez I
    Ann Hum Genet; 2019 Jul; 83(4):266-273. PubMed ID: 30888062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathology of ataxia telangiectasia.
    Taylor AM; Byrd PJ
    J Clin Pathol; 2005 Oct; 58(10):1009-15. PubMed ID: 16189143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telangiectasias in Ataxia Telangiectasia: Clinical significance, role of ATM deficiency and potential pathophysiological mechanisms.
    Schoenaker MHD; Van Os NJH; Van der Flier M; Van Deuren M; Seyger MM; Taylor AMR; Weemaes CMR; Willemsen MAAP
    Eur J Med Genet; 2018 May; 61(5):284-287. PubMed ID: 29288088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorder.
    Fernet M; Gribaa M; Salih MA; Seidahmed MZ; Hall J; Koenig M
    Hum Mol Genet; 2005 Jan; 14(2):307-18. PubMed ID: 15574463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS.
    Shull ER; Lee Y; Nakane H; Stracker TH; Zhao J; Russell HR; Petrini JH; McKinnon PJ
    Genes Dev; 2009 Jan; 23(2):171-80. PubMed ID: 19171781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very mild presentation in adult with classical cellular phenotype of ataxia telangiectasia.
    Worth PF; Srinivasan V; Smith A; Last JI; Wootton LL; Biggs PM; Davies NP; Carney EF; Byrd PJ; Taylor AM
    Mov Disord; 2013 Apr; 28(4):524-8. PubMed ID: 23143971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional classification of ATM variants in ataxia-telangiectasia patients.
    Fiévet A; Bellanger D; Rieunier G; Dubois d'Enghien C; Sophie J; Calvas P; Carriere JP; Anheim M; Castrioto A; Flabeau O; Degos B; Ewenczyk C; Mahlaoui N; Touzot F; Suarez F; Hully M; Roubertie A; Aladjidi N; Tison F; Antoine-Poirel H; Dahan K; Doummar D; Nougues MC; Ioos C; Rougeot C; Masurel A; Bourjault C; Ginglinger E; Prieur F; Siri A; Bordigoni P; Nguyen K; Philippe N; Bellesme C; Demeocq F; Altuzarra C; Mathieu-Dramard M; Couderc F; Dörk T; Auger N; Parfait B; Abidallah K; Moncoutier V; Collet A; Stoppa-Lyonnet D; Stern MH
    Hum Mutat; 2019 Oct; 40(10):1713-1730. PubMed ID: 31050087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mre11 ATLD17/18 mutation retains Tel1/ATM activity but blocks DNA double-strand break repair.
    Limbo O; Moiani D; Kertokalio A; Wyman C; Tainer JA; Russell P
    Nucleic Acids Res; 2012 Dec; 40(22):11435-49. PubMed ID: 23080121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe reaction to radiotherapy for breast cancer as the presenting feature of ataxia telangiectasia.
    Byrd PJ; Srinivasan V; Last JI; Smith A; Biggs P; Carney EF; Exley A; Abson C; Stewart GS; Izatt L; Taylor AM
    Br J Cancer; 2012 Jan; 106(2):262-8. PubMed ID: 22146522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.